ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
RITUXIMAB: products 1 to 4 of 4.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Riximyo 10mg/mL Inj Sol (Preservative-Free)DIN 02498316 | Limited Use, codes 581, 582, 616, 617 | $29.7000per source unit | Requirements & sourcesBuild cost plan |
| Ruxience 10mg/mL Inj Sol (Preservative-Free)DIN 02495724 | Limited Use, codes 583, 584, 585, 586 | $29.7000per source unit | Requirements & sourcesBuild cost plan |
| Truxima 100mg/10mL Inj Sol-10mL Vial PkDIN 02478382 | Limited Use, codes 575, 576, 587, 588 | $297.0000per source unit | Requirements & sourcesBuild cost plan |
| Truxima 500mg/50mL Inj Sol-50mL Vial PkDIN 02478390 | Limited Use, codes 575, 576, 587, 588 | $1485.0000per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.